DermTech, Inc. is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA.
Company profile
Website
CEO
John D. Dobak
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DermTech International
SEC CIK
Corporate docs
Latest filings (excl ownership)
D/A
$15.51M in equity / options, sold $10.01M, 16 investors
7 Feb 18
D/A
$15.51M in equity / options, sold $9.6M, 15 investors
5 Dec 17
D/A
$15.51M in equity / options, sold $7.07M, 12 investors
30 Jun 17
D/A
$15.51M in equity / options, sold $3.12M, 5 investors
13 Dec 16
D
$15.51M in equity / options, sold $2.07M, 3 investors
21 Oct 16
D/A
$20M in equity / options, sold $4.31M, 8 investors
12 Nov 15
D/A
$20M in equity / options, sold $1.77M, 4 investors
11 Sep 15
D/A
$20M in equity / options, sold $772.32K, 2 investors
26 Aug 15
D
$20M in equity / options, sold $583.64K, 2 investors
14 Aug 15
D
$2.44M in debt / options / securities to be acquired, sold $2.44M, 16 investors
15 Apr 15
Latest ownership filings